References
- Arai M, Scandella D, Hoyer L W. Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid. J Clin Invest 1989; 83: 1978–1984
- Daha M R. Autoantibodies to complement components. Complement in health and disease, K Whaley. MTP Press, London 1987; 185–199
- Jackson J, Sim R B, Whelan A, Feighery C. An IgG autoantibody which inactivates CI-Inhibitor. Nature 1986; 323: 122–724
- Alsenz J, Bork K, Loos M. Autoantibody-mediated acquired deficiency of C1–Inhibitor. N Eng J Med 1987; 316: 1360–1366
- Malbran A, Hammer C H, Frank M M, Fries L F. Acquired angioedema: Observations on the mechanism of action of autoantibodies directed against C1 esterase inhibitor. J Allergy Clin Immunol 1988; 81: 1199–1204
- Landerman N S, Webster M E, Becker E L, Ratcliffe H E. Hereditary angioneurotic edema. II Deficiency of inhibitor for serum globulin permiability factor and/or plasma kallikrein. J Allergy 1962; 33: 330–341
- Donaldson V H, Evans R R. A biochemical abnormality in hereditary angioeurotic edema. Am J Med 1963; 35: 37–44
- Sim R B, Reboul A. Preparation and properties of human C1–inhibitor. Methds Enzymol 1981; 80: 43–54
- Travis J, Salvesen G S. Human plasma proteinase inhibitors. Ann Rev Eiochem 1983; 52: 655–709
- Zuraw B L, Curd J G. Demonstration of modified inactive first component of complement (CI) inhibitor in the plasmas of CI-inhibitor-deficient patients. J Clin Invest 1986; 78: 567–575
- Frank M M, Gelfand J A, Atkinson J P. Hereditary angioedema: the clinical syndrome and its management. Ann Infern Med 1976; 84: 580–593
- Gelfand J A, Boss G R, Conley C L, Reinhart R, Frank M A. Acquired CI esterase inhibitor deficiency and angioedema: A review. Medicine 1979; 58: 321–328
- Sheffer A L, Austen K F, Rosen F S, Fearon D T. Acquired deficiency of the inhibitor of the first component of complement: report of five additional cases with commentary on the syndrome. J Allergy Clin Immunol 1985; 76: 640–646
- Geha R S, Quinti L, Austen K F, Cicardi M, Sheffer A, Rosen F S. Acquired CI-Inhibitor deficiency associated with anti-idiotypic antibody to monoclonal immunoglobulins. N England J Med 1985; 312: 534–540
- Frank M M, Malbran A, Simms H, Melez K, Santaella M, Hammer C, Fries L. Acquired angioedema type 11 (AAE-11). Clin Res 1987; 35: 641, Abs
- Jackson J, Sim R B, Feighery C. Affinity of anti-CI-inhibitor antibody for normal CI-inhibitor in autoimmune angioedema. Proc 7 Intern Cong Immunol 1989; W25–9
- Alsenz J, Loos M. The acquired CI-inhibitor deficiences with autoantibodies (AAE type 11). Behring Inst Mitt. 1989; 84: 165–172
- Jackson J, Sim R B, Whaley K, Jones I, Feighery C. Autoantibody-mediated cleavage of normal CI-Inh by purified Clr, CIS and plasmin. Complement 1987; 4: 173, abs
- Jackson J, Sim R B, Whaley K, Feighery C. Autoantibody facilitated cleavage of CI-inhibitor in autoimmune angioedema. J Clin Invest 1989; 83: 698–707
- Jackson J, Feighery C. Autoantibody-mediated acquired deficiency of CI-inhibitor. N Eng J Med 1988; 318: 122–123
- Alsenz J, Bork K, Loos M. Autoantibody-mediated acquired deficiency of CI-inhibitor. N Eng J Med 1988; 318: 123
- Alsenz J, Lambris J D, Bork K, Loos M. Acquired CI-inhibitor (CI-Inh) deficiency type 11. J. Cdin Invest 1989; 83: 1794–1799